Mutations in two-component signaling systems drive experimental evolution of tigecycline and colistin resistance in <i>Acinetobacter baumannii</i>James E. Kent, Andrei L. Osterman, Andreas Haldimann et al.|Antimicrobial Agents and Chemotherapy|2025Cited by 1